Clinical trialNCT05280314RecruitingPhase 2Interventional

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

SponsorIO BiotechEnrollment60MelanomaSquamous Cell Carcinoma of Head and Neck

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Barbara Burtness, MD, Prof
Yale New Haven Hospital - Yale Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Melanoma Institute Australia the Uiniversity of Sydney, and Royal North Shore Hospital
Sydney, New South Wales, Australia
Georgina Long, MD
Recruiting
Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Annette Lim, DrShahneen Sandhu, Dr
Recruiting

Denmark

Aarhus University Hospital
Aarhus, Denmark
Rasmus Friis, Dr
Recruiting
Copenhagen University Hospital Herlev
Copenhagen, Denmark
Inge Marie Svane, Dr
Recruiting

France

Chru Lille
Lille, France
Laurent Mortier, MD
Recruiting
Hôpital Ambroise-Paré
Paris, France
Philippe Saiag, MD
Recruiting
Institut Gustave Roussy
Paris, France
Caroline Robert, MD
Recruiting

Germany

Universitätsklinikum Essen & Research Alliance Ruhr
Essen, Germany
Dirk Schadendorf, MD
Recruiting
Universität Heidelberg, Medizinische Fakultät
Heidelberg, Germany
Jessica Hassell, MD
Recruiting

Spain

Hospital Universitario Quirón Dexeus
Barcelona, Spain
Maria González Cao, Dr
Recruiting
Hospital Universitario Ramón Y Cajal
Madrid, Spain
Aimaria Soria, Dr
Recruiting
Hospital Clínico Universitario de Valencia -Incliva
Valencia, Spain
Ines González, Dr
Recruiting

United States

Yale
New Haven, Connecticut, United States
Barbara Burtness
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Robert Haddad
Recruiting
Massey Cancer Center
Richmond, Virginia, United States
Erin Alesi, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Dec 2023
Primary completion: 30 Apr 2025
Completion: 31 Jan 2027
Last update posted: 18 Mar 2024
Registered enrollment: 60
Registry id: NCT05280314

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.